Please use this identifier to cite or link to this item:
                
    
    http://localhost:8080/xmlui/handle/123456789/68Full metadata record
| DC Field | Value | Language | 
|---|---|---|
| dc.contributor.author | Sitar Solomon | - | 
| dc.contributor.author | Arya P.B. (Guided by) | - | 
| dc.date.accessioned | 2021-07-30T11:46:45Z | - | 
| dc.date.available | 2021-07-30T11:46:45Z | - | 
| dc.date.issued | 2020-10 | - | 
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/68 | - | 
| dc.publisher | The National University of Advanced Legal Studies | en_US | 
| dc.subject | TRIPS Agreement | en_US | 
| dc.subject | Pharmaceutical | en_US | 
| dc.subject | Public Health in India | en_US | 
| dc.title | Implications of the trips agreement on domestic pharmaceutical industry and public health in India | en_US | 
| dc.type | LL.M Dissertation | en_US | 
| Appears in Collections: | 2019 - 2020 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| LM0219012 ITL.pdf | 825.04 kB | Adobe PDF | ![]() View/Open  | 
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
        